FFCP PHASE1:Hg19::chr2:150961763..150961789,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=not supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C158 | |||
|description=CAGE_peak_at_chr2:150961763..150961789,- | |||
|id=chr2:150961763..150961789,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:4468!4.52e-50!2;DOID:299!4.64e-17!25 | |||
|ontology_enrichment_disease_v019=DOID:299;2.15e-09;25!DOID:7;2.32e-07;39 | |||
|ontology_enrichment_disease_v019_2=DOID:299,2.15e-09,25 | |||
|ontology_enrichment_uberon=UBERON:0002369!4.27e-34!3;UBERON:0001235!4.27e-34!3;UBERON:0006858!4.27e-34!3;UBERON:0002342!1.86e-08!14;UBERON:0005062!1.86e-08!14;UBERON:0001851!1.45e-07!16 | |||
|ontology_enrichment_uberon_v019=UBERON:0002369;2.39e-66;3!UBERON:0001235;2.39e-66;3!UBERON:0006858;2.39e-66;3!UBERON:0001851;1.22e-14;15!UBERON:0002368;2.32e-07;33 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002369,2.39e-66,3;UBERON:0001235,2.39e-66,3;UBERON:0006858,2.39e-66,3;UBERON:0001851,1.22e-14,15;UBERON:0003064,1.52e-08,28;UBERON:0002368,4.03e-07,35 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.28163130497081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163232808159148,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:150961763..150961789,- | |||
}} |
Revision as of 05:55, 21 January 2014
Short description: | p@chr2:150961763..150961789, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | No |
Description: | CAGE_peak_at_chr2:150961763..150961789, - |
Coexpression cluster: | C158_adrenal_gastric_temporal_parietal_duodenum_caudate_putamen |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
adrenal gland | 2.39e-66 | 3 |
adrenal cortex | 2.39e-66 | 3 |
adrenal/interrenal gland | 2.39e-66 | 3 |
cortex | 1.22e-14 | 15 |
intermediate mesoderm | 1.52e-08 | 28 |
endocrine gland | 4.03e-07 | 35 |
Ontology term | p-value | n |
---|---|---|
adenocarcinoma | 2.15e-09 | 25 |